Introduction
Methods
Development of draft outcomes set based on existing questionnaires and input from survivors
Selection of self-reported long-term physical outcomes for CCS
Comparison between CTCAE and the new Dutch LATER core outcome set
Results
Selection of self-reported long-term physical outcomes of clinical relevance
Self-reported long-term physical outcome | Definition of clinical relevance | |
---|---|---|
Eye disorders | Cataract | Cataract of at least one eye treated with surgery |
Blindness | Blindness of at least one eye | |
Eye removal | Status after removal of at least one eye | |
Ear | Hearing loss | Hearing loss of at least one ear, requiring a hearing aid |
conditions | Deafness | Deafness of at least one ear |
Cardiac conditions | Heart failure | Heart failure with clinical symptoms, with at least one of the following criteria: 1. Requiring medication (ACE inhibitors, beta-blockers, mineralocorticoid receptor antagonists, aldosterone receptor antagonists, diuretics, angiotensin II blockers, digoxin) 2. Requiring devices (CRT-P or CRT-D, pacemaker, ICD, LVAP, cardiac reduction surgery) |
Ischemia | Cardiac ischemia with clinical symptoms requiring intervention (angioplasty, stent, coronary bypass graft) | |
Pericarditis | Pericarditis with clinical symptoms, with at least one of the following criteria: 1. Life-threatening consequences (hemodynamic comprise, tamponade)2. Requiring surgical intervention (pericardiectomy) | |
Valvular disease | Valvular disease with clinical symptoms, with at least one of the following criteria: 1. Requiring medication (ACE inhibitors, calcium channel blockers, beta-blockers, enalapril, diuretics, digoxin) 2. Requiring valve replacement or valvuloplasty | |
Arrhythmia | Arrhythmia with clinical symptoms, with at least one of the following criteria: 1. Requiring medication (beta-blockers, digoxin, calcium channel blockers, amiodarone, sotalol, flecainide, propafenone, electrolytes, anti-thrombines, anti-platelets, N-3 fatty acid and lipids) 2. Requiring device or surgical intervention (ICD, pacemaker, CRT-P, CRT-D, ablation, antiarrhythmic surgery, cardioversion) | |
Heart transplantation | Status after heart transplantation | |
Vascular conditions | Hypertension | Hypertension, requiring antihypertensive medication (ACE inhibitors, beta blockers, diuretics, calcium antagonists, angiotensin II antagonists, alfa blockers) |
Thrombosis | Thrombosis or a thromboembolic event, with at least one of the following criteria: 1. Requiring chronic treatment with antithrombotic agents 2. Requiring surgical intervention | |
Aneurysm | The presence of an aneurysm (confirmed by medical imaging), requiring surgical intervention | |
Respiratory conditions | Obstructive pulmonary disease | Pulmonary obstructive disease (i.e., asthma, COPD, chronic bronchitis), with clinical symptoms, with at least one of the following criteria: 1. Requiring chronic medication (beclometason, fluticasone proprionate, ciclesonide, salmeterol, beclomethasone/formoterol, budesonide/formoterol, salmeterol/estril, montelukast) 2. Requiring chronic oxygen treatment *Only intermittent therapy with acute bronchodilators is not defined as clinically relevant |
Decreased pulmonary function | Decreased pulmonary function confirmed by spirometry function, which results in limitations in daily life on participation level (i.e., due to the pulmonary condition unable to function in work, hobbies, household, or social circumstances) *Asymptomatic decreased lung function without symptoms detected during routine screening is not defined as clinically relevant | |
Pulmonary resection | Status after surgery to remove (part of a) lung after which symptoms of decreased pulmonary function are present | |
Pulmonary transplantation | Transplantation of one or more lungs after which symptoms of decreased pulmonary function are present | |
Other pulmonary conditions | Other pulmonary conditions (including bullae, pulmonary edema, pleuritis) with clinical symptoms, confirmed by clinical evaluation, with at least one of the following criteria: 1. Requiring medical treatment with medication or surgery 2. Resulting in limitations in daily life on participation level (due to the pulmonary condition unable to function in work, hobbies, household or social circumstances) | |
Gastro-intestinal | Gastroesophageal reflux disease | Gastroesophageal reflux disease, with clinical symptoms, requiring anti acid medication |
Inflammatory bowel disease | Inflammatory bowel disease (i.e., Crohn and Colitis ulcerosa) with clinical symptoms, with at least one of the following criteria: 1. Requiring treatment with immunosuppressive medication 2. Requiring surgical intervention | |
Other gastrointestinal conditions | Gastro-intestinal health conditions, not otherwise specified, with clinical symptoms, causing mechanical problems (i.e., adhesions, ileus, stenosis, stoma), with at least one of the following criteria: 1. Requiring chronic tube feeding 2. Requiring chronic total parenteral feeding 3. Requiring surgical intervention 4. The presence of a stoma 5. The removal of (part of the) jaw | |
Hepatobiliary conditions | Hepatitis | Chronic infection with hepatitis B or C, with at least one of the following criteria: 1. Requiring at least one of the listed medication (interferon or antiviral medication) 2. Resulting in liver cirrhosis |
Hemochromatosis | Hemochromatosis (iron overload), with clinical symptoms, with at least one of the following criteria: 1. Requiring treatment with phlebotomy or erythrocytopheresis 2. Requiring iron lowering medication | |
Liver cirrhosis | Cirrhosis of the liver with clinical symptoms | |
Liver transplantation | Status after liver transplantation | |
Cholecystectomy | Status after cholecystectomy | |
Renal and urinary tract | Tubular dysfunction | The presence of renal tubular dysfunction with clinical symptoms, resulting in electrolyte imbalance requiring medication |
conditions | Proteinuria | Proteinuria confirmed by urine analysis, requiring treatment with medication (ACE inhibitors, thiazide diuretics) |
Chronic kidney disease | Renal insufficiency with clinical symptoms, requiring medical treatment with at least one of the following: 1. Antihypertensive drugs (ACE inhibitors, angiotensin II antagonists, diuretics) 2. Medication for proteinuria (ACE inhibitors or thiazide diuretics) 3. Medication for the prevention of cardiovascular complications (statins) 4. Medication for anemia (EPO) 5. Medication for osteodystrophia (phosphate binding medicine, active vitamin D) 6. Medication for electrolyte deficiencies/tubular dysfunction 7. Dialysis 8. Renal transplantation | |
Urinary tract obstruction | Urinary tract obstruction with clinical symptoms, requiring surgical intervention | |
Nephrectomy | Status after the removal of at least one kidney | |
Renal transplantation | Status after transplantation of one (or more) kidney(s) | |
Other conditions of kidney and urinary tract | Other conditions of kidney and urinary tract with clinical symptoms, including: 1. The presence of an urine stoma 2. Incontinence, requiring surgical intervention 3. The need for structural catheterization 4. Dialysis 5. Removal of bladder 6. Elevated uric acid treated with chronic medication | |
Endocrine conditions | Adrenal insufficiencyB | Adrenal insufficiency with clinical symptoms and confirmed by laboratory testing, requiring hormonal treatment (glucocorticoids, mineralocorticoids) |
Hypercortisolism | Hypercortisolism (Cushing’s disease) with clinical symptoms and confirmed by laboratory testing, with at least one of the following criteria: 1. Requiring surgical intervention 2. Requiring radiation therapy 3. Requiring post-treatment substitution therapy (hydrocortisone) | |
HypothyroidismB | Hypothyroidism with clinical symptoms and confirmed by laboratory testing requiring treatment with chronic medication (levothyroxine) | |
Hyperthyroidism | Hyperthyroidism with clinical symptoms and confirmed by laboratory testing, with at least one of the following criteria: 1. Requiring iodine treatment (radioactive) 2. Requiring surgical intervention (i.e., (hemi)thyroidectomy) 3. Requiring medication (i.e., thyreostatics or thyroid suppletion therapy for iatrogenic hypothyroidism) | |
Estrogen deficiencyB | Estrogen deficiency with clinical symptoms and confirmed by laboratory testing, with at least one of the following criteria: 1. Requiring treatment with transdermal estrogen 2. Requiring chronic medication (oral estrogen) | |
Testosterone deficiencyB | Testosterone deficiency with clinical symptoms and confirmed by laboratory testing, requiring treatment with: Testosterone | |
Growth hormone deficiencyB | Growth hormone deficiency with clinical symptoms and confirmed by laboratory testing, with at least one of the following criteria: 1. Requiring medical treatment with growth hormone 2. For which growth hormone treatment was indicated, but the treating physician and/or parents decided not to start this treatment because of medical contra-indications | |
Hypoparathyroidism | Hypoparathyroidism with clinical symptoms and confirmed by laboratory testing, with at least one of the following criteria: 1. Requiring calcium suppletion 2. Requiring active vitamin D3 (calcitriol or etalpha) | |
Hyperparathyroidism | Hyperparathyroidism with clinical symptoms and confirmed by laboratory testing, requiring surgical intervention | |
Prolactinoma | Prolactinoma with clinical symptoms and confirmed by laboratory testing, with at least one of the following criteria: 1. Requiring treatment with dopamine agonists 2. Requiring surgical treatment | |
Polycystic ovarian syndrome | The presence of polycystic ovarian syndrome with clinical symptoms, confirmed by imaging | |
Precocious puberty | Early puberty, that has been, or is currently treated with medication (puberty inhibiting medicine, i.e., GnRH analogues) | |
Pubertas tarda | Late puberty, that has been or is currently treated with medication (sex steroids) | |
Pituitary deficiency | Pituitary deficiency, with clinical symptoms and confirmed by laboratory testing, with at least one of the following criteria: 1. Requiring growth hormone treatment 2. Requiring thyroid hormone treatment 3. Requiring hydrocortisone treatment 4. Requiring sex hormone treatment 5. Requiring desmopressin treatment | |
Pituitary surgery | Status after surgery to the pituitary gland | |
Obesity | The presence of obesity according to the World Health Organization’s standardized definition of obesity for adults: BMI > 30, or for children > + 2 SDS in corrected for age and sex according to Dutch normative dataA | |
Underweight | The presence of underweight according to the World Health Organization’s standardized definition of underweight for adults: BMI < 18.5, or for children < − 2 SDS corrected for age and sex according to Dutch normative dataA | |
Diabetes mellitus | Diabetes mellitus with confirmed by laboratory testing with at least one of the following criteria: 1. Requiring treatment with oral antidiabetic agents 2. Requiring treatment with intramuscular or intravenous insulin | |
Diabetes insipidusB | Diabetes insipidus with clinical symptoms and confirmed by laboratory testing, requiring treatment with medication (desmopressin) | |
Thyroidectomy | Status after (partial) thyroidectomy, after which medication use (levothyroxine) is required | |
Adrenal gland removal | Status after the removal of one or two adrenal gland(s) | |
Ovariectomy | Status after the removal of one or more ovaria | |
Orchidectomy | Status after the removal of one or more testes | |
Nervous system conditions | Cerebrovascular accident—hemorrhagic | Intracranial hemorrhage with clinical symptoms and confirmed by imaging, with at least one of the following criteria: 1. Requiring surgical intervention 2. Requiring medication (antihypertensive drugs) |
Cerebrovascular accident—ischemic | Intracerebral infarction with clinical symptoms and confirmed by imaging, requiring treatment with medication (acetylsalicylic acid, dipyridamole, statins, or antihypertensive agents) | |
Transient ischemic attack | The presence of a transient ischemic attack (duration < 24 h) with clinical symptoms, requiring treatment with medication (acetylsalicylic acid, dipyridamole, statins, or antihypertensive agents) | |
Epilepsy | Epilepsy with clinical symptoms and confirmed by electro-encephalography, requiring treatment with medication (carbamazepine, lamotrigine, levetiracetam, oxcarbezepine, valproate, clonazepam, phenytoin, gabapentin, lacosamide, perampanel, pregabalin, topiramate, zonisamide, clonazepam) | |
Headache | Headache (migraine, cluster headache) resulting in clinical symptoms treated with at least one of the following criteria: 1. Requiring treatment with beta blockers, anti-epileptic medication, flinarizine, pizotifen, methysergide, or candesartan (migraine) 2. Requiring treatment with verapamil, lithium carbonate, methysergide, pizotifen, ergotamine, or prednisone (cluster headache) | |
Hydrocephalus | The presence of hydrocephalus, requiring surgical intervention | |
Other neurological conditions | The presence of other neurologic conditions, with clinical symptoms, including facialis paresis, spinal cord injury, (spastic) paresis, loss of strength, disturbance of equilibrium, coordination problems, vertigo, acquired brain injury, tremor, parkinsonism, ataxia) | |
Musculoskeletal conditions | Amputation | Status after the amputation of a (part of a) limb, excluding fingers and toes |
Deformities | The presence of at least one of the following major deformities (scoliosis, kyphosis, lordosis, or spondylolisthesis) with clinical symptoms | |
Osteoporosis | Osteoporosis confirmed with a DEXA scan, requiring treatment with chronic medication (bisphosphonates, estrogen receptor modulators, or parathyroid hormone) | |
Other musculoskeletal conditions | At least one of the following conditions with clinical symptoms: arthritis (bacterial, gout, reactive, rheumatoid arthritis), arthrosis, osteonecrosis, epiphysiolysis, with at least one of the following criteria: 1. Requiring medication (allopurinol, benzbromaron, leflunomide, methotrexate, sulfasalazine, infliximab, adalimumab, etanercept, certolizumab, anti-IL1, anti-CD80, anti-CD86, aurothiomalaat, ciclosporin, hydroxychloroquinine, cyclophosphamide) 2. Requiring therapy using intra-articular injection(s) 3. Requiring joint replacement surgery 4. Requiring arthrodesis surgery | |
Neoplasms | Malignant neoplasms | Malignant neoplasms of any kind |
Other conditions | Dermatological conditions | Dermatological conditions with clinical symptoms and that require systematic treatment |
Hysterectomy | Status after the removal of the uterus | |
Prostatectomy | Status after the removal of the prostate | |
Mastectomy | Status after the removal of one or more breast(s) | |
Splenectomy | Status after splenectomy |